|Drug Name||GPCR-targeted Project 016|
Frizzled 7 (FZD7) is a critical receptor for Wnt signaling, which binds to Wnt proteins to activate either canonical or noncanonical Wnt signaling pathways. The Wnt/β-catenin signaling pathway is involved in the regulation of cell proliferation, differentiation, migration, apoptosis, and survival, and has been shown to be dysregulated in cancers.
|Target||Frizzled 7 (FZD7)|
|Drug Modality||Monoclonal antibody|
|Mechanism of Action||Frizzled 7 antagonists|
We look forward to hearing from you.
Protheragen's business is growing rapidly after founded in Ronkonkoma, New York. Our business has evolved from the initial intermediary service to encompass segments in equity investment and program incubation.